Evidence map›Paper›PMID 31263204›Full record

ArticleJournal of perinatology : official journal of the California Perinatal Association2020

Frequency-following response among neonates with progressive moderate hyperbilirubinemia.

Gabriella Musacchia, Jiong Hu, Vinod K Bhutani, Ronald J Wong, Mei-Ling Tong, Shuping Han, Nikolas H Blevins, Matthew B Fitzgerald

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of perinatology : official journal of the California Perinatal Association, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.3field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. TcB, FFR, phototherapy and the persistent occurrence of kernicterus spectrum disorder.Journal of perinatology : official journal of the California Perinatal Association · 2020
    Article
  6. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Gabriella MusacchiaDepartment of Audiology, University of the Pacific, San Francisco, CA, 94103, USA. gmusacchia@pacific.edu.ORCID http://orcid.org/0000-0001-8895-9096
Jiong HuDepartment of Audiology, University of the Pacific, San Francisco, CA, 94103, USA.
Vinod K BhutaniDepartment of Pediatrics, Division of Neonatal and Developmental Medicine, Stanford University, Stanford, CA, 94305, USA.ORCID http://orcid.org/0000-0003-0770-6543
Ronald J WongDepartment of Pediatrics, Division of Neonatal and Developmental Medicine, Stanford University, Stanford, CA, 94305, USA.ORCID http://orcid.org/0000-0003-1205-6936
Mei-Ling TongDepartment of Pediatrics, Nanjing Maternal and Child health Hospital of Nanjing Medical University, Nanjing, China.
Shuping HanDepartment of Pediatrics, Nanjing Maternal and Child health Hospital of Nanjing Medical University, Nanjing, China.
Nikolas H BlevinsDepartment of Otolaryngology - Head and Neck Surgery, Stanford University, Stanford, CA, 94305, USA.
Matthew B FitzgeraldDepartment of Otolaryngology - Head and Neck Surgery, Stanford University, Stanford, CA, 94305, USA.
Stanford University · USNanjing Maternity and Child Health Care Hospital · CNUniversity of the Pacific · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo evaluate the feasibility of auditory monitoring of neurophysiological status using frequency-following response (FFR) in neonates with progressive moderate hyperbilirubinemia, measured by transcutaneous (TcB) levels. STUDY

designABR and FFR measures were compared and correlated with TcB levels across three groups. Group I was a healthy cohort (n = 13). Group II (n = 28) consisted of neonates with progressive, moderate hyperbilirubinemia and Group III consisted of the same neonates, post physician-ordered phototherapy.

resultFFR amplitudes in Group I controls (TcB = 83.1 ± 32.5µmol/L; 4.9 ± 1.9 mg/dL) were greater than Group II (TcB = 209.3 ± 48.0µmol/L; 12.1 ± 2.8 mg/dL). After TcB was lowered by phototherapy, FFR amplitudes in Group III were similar to controls. Lower TcB levels correlated with larger FFR amplitudes (r = -0.291, p = 0.015), but not with ABR wave amplitude or latencies.

conclusionThe FFR is a promising measure of the dynamic neurophysiological status in neonates, and may be useful in tracking neurotoxicity in infants with hyperbilirubinemia.

Indexed as

Acoustic StimulationEvoked Potentials, Auditory, Brain StemBilirubinBrain StemCohort StudiesElectroencephalographyHumansHyperbilirubinemia, NeonatalInfant, NewbornNeonatal ScreeningPhototherapySpeechBilirubin

Identifiers

PMID31263204
OpenAlexW2954831388

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.